Urology Practice Management - August 2015, Vol 4, No 4

AUA Addresses Integration of Advanced Practice Providers in Urology Practices
The skillful integration of advanced practice providers (APPs) into urology practices can help address issues related to the dwindling urologist workforce shortage and the aging of practicing urologists. Read More ›

AUA Incorporates Member Feedback in New “Choosing Wisely” Recommendations
The American Urological Association (AUA)’s second set of Choosing Wisely recommendations, released June 11, 2015, incorporates feedback from the organization’s membership, which is a new approach for the group. Read More ›

ICD-10 Train Heads Full Speed to October 1 Deadline, AUA Advises
Urology practices must have a plan in place to transition to the International Classification of Diseases, Tenth Revision (ICD-10) by October 1, 2015, and should not expect any further delays in implementation, according to the American Urological Association (AUA). Read More ›

A winning approach to preauthorization begins with providers and payers “dancing in sync,” said Kenneth T. Hertz, FACMPE, Medical Practice Consultant, Medical Group Management Association, Alexandria, LA, at the 2015 American Urological Association (AUA) annual meeting. Read More ›

Recently retired and looking back over my decades in the workforce, I see gender issues once again gaining strength. I was raised to believe there were no gender barriers or limitations, and most of what I have seen in my youth and working years has supported that. Read More ›

The sound that is getting impossible to ignore is the clock ticking down to the implementation of the International Classification of Diseases, Tenth Edition (ICD-10) at 12:01 am on Thursday, October 1, 2015. Read More ›

Adding docetaxel (Taxotere) to standard hormone therapy extends overall survival (OS) by a median of 10 months versus hormone therapy alone in men with newly diagnosed, advanced, hormone therapy–naïve prostate cancer, according to the results of the STAMPEDE trial. Read More ›

Enzalutamide (Xtandi) outperformed bicalutamide (Casodex) in 2 separate phase 2 clinical trials of men with prostate cancer, according to data presented at the 2015 American Urological Association annual meeting. Read More ›

The following clinical trials are currently recruiting patients with urinary tract infections for inclusion in several investigations. Read More ›

It is a fact of life. The current tax system rewards taxpayers who are aggressive with their deductions. To find out what people are deducting, we undertook an informal survey of many of our colleagues who are certified public accountants. We found that a handful of deductions show up repeatedly on the tax returns of those taxpayers who tend to be very aggressive with their deductions. How aggressive are you with the deductions you claim on your income tax return each year? Below we discuss some of the more common deductions we have found. Read More ›

Subscribe to
Urology Practice Management

Stay up to date with urology news & updates by subscribing to recieve the free UPM print publications or weekly e‑Newsletter.

I'd like to recieve: